233 related articles for article (PubMed ID: 36071171)
1. Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
Baca SC; Singler C; Zacharia S; Seo JH; Morova T; Hach F; Ding Y; Schwarz T; Huang CF; Anderson J; Fay AP; Kalita C; Groha S; Pomerantz MM; Wang V; Linder S; Sweeney CJ; Zwart W; Lack NA; Pasaniuc B; Takeda DY; Gusev A; Freedman ML
Nat Genet; 2022 Sep; 54(9):1364-1375. PubMed ID: 36071171
[TBL] [Abstract][Full Text] [Related]
2. Variants at IRX4 as prostate cancer expression quantitative trait loci.
Xu X; Hussain WM; Vijai J; Offit K; Rubin MA; Demichelis F; Klein RJ
Eur J Hum Genet; 2014 Apr; 22(4):558-63. PubMed ID: 24022300
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
[TBL] [Abstract][Full Text] [Related]
4. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive functional annotation of 77 prostate cancer risk loci.
Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
[TBL] [Abstract][Full Text] [Related]
6. Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs.
Brown CD; Mangravite LM; Engelhardt BE
PLoS Genet; 2013; 9(8):e1003649. PubMed ID: 23935528
[TBL] [Abstract][Full Text] [Related]
7. Principles of microRNA Regulation Revealed Through Modeling microRNA Expression Quantitative Trait Loci.
Budach S; Heinig M; Marsico A
Genetics; 2016 Aug; 203(4):1629-40. PubMed ID: 27260304
[TBL] [Abstract][Full Text] [Related]
8. H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Giambartolomei C; Seo JH; Schwarz T; Freund MK; Johnson RD; Spisak S; Baca SC; Gusev A; Mancuso N; Pasaniuc B; Freedman ML
Am J Hum Genet; 2021 Dec; 108(12):2284-2300. PubMed ID: 34822763
[TBL] [Abstract][Full Text] [Related]
9. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
10. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
[TBL] [Abstract][Full Text] [Related]
11. Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types.
Li Q; Stram A; Chen C; Kar S; Gayther S; Pharoah P; Haiman C; Stranger B; Kraft P; Freedman ML
Hum Mol Genet; 2014 Oct; 23(19):5294-302. PubMed ID: 24907074
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
[TBL] [Abstract][Full Text] [Related]
13. Characterization of expression quantitative trait loci in the human colon.
Singh T; Levine AP; Smith PJ; Smith AM; Segal AW; Barrett JC
Inflamm Bowel Dis; 2015 Feb; 21(2):251-6. PubMed ID: 25569741
[TBL] [Abstract][Full Text] [Related]
14. Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression.
Larson NB; McDonnell S; French AJ; Fogarty Z; Cheville J; Middha S; Riska S; Baheti S; Nair AA; Wang L; Schaid DJ; Thibodeau SN
Am J Hum Genet; 2015 Jun; 96(6):869-82. PubMed ID: 25983244
[TBL] [Abstract][Full Text] [Related]
15. DNase I sensitivity QTLs are a major determinant of human expression variation.
Degner JF; Pai AA; Pique-Regi R; Veyrieras JB; Gaffney DJ; Pickrell JK; De Leon S; Michelini K; Lewellen N; Crawford GE; Stephens M; Gilad Y; Pritchard JK
Nature; 2012 Feb; 482(7385):390-4. PubMed ID: 22307276
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.
Shetty A; Seo JH; Bell CA; O'Connor EP; Pomerantz MM; Freedman ML; Gusev A
Am J Hum Genet; 2021 Nov; 108(11):2071-2085. PubMed ID: 34699744
[TBL] [Abstract][Full Text] [Related]
17. Gene regulatory mechanisms underpinning prostate cancer susceptibility.
Whitington T; Gao P; Song W; Ross-Adams H; Lamb AD; Yang Y; Svezia I; Klevebring D; Mills IG; Karlsson R; Halim S; Dunning MJ; Egevad L; Warren AY; Neal DE; Grönberg H; Lindberg J; Wei GH; Wiklund F
Nat Genet; 2016 Apr; 48(4):387-97. PubMed ID: 26950096
[TBL] [Abstract][Full Text] [Related]
18. Chromatin interactions and candidate genes at ten prostate cancer risk loci.
Du M; Tillmans L; Gao J; Gao P; Yuan T; Dittmar RL; Song W; Yang Y; Sahr N; Wang T; Wei GH; Thibodeau SN; Wang L
Sci Rep; 2016 Mar; 6():23202. PubMed ID: 26979803
[TBL] [Abstract][Full Text] [Related]
19. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
